Reference lists for PSC Support publications
Bacterial Cholangitis Leaflet Ref: BC 1.3
Bacterial Cholangitis Leaflet Ref: BC 1.4
Bacterial Cholangitis Leaflet Ref: BC 1.5
- Chapman RW. Primary sclerosing cholangitis. Medicine International. 2015;43(11):648–652.
- Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. The Lancet. 2013;382(9904):1587-1599.
- Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis–a comprehensive review. Journal of hepatology. 2017 Aug 10.
Specialist reviewers: Dr Roger W. Chapman, Dr Kate Lynch (née Williamson)
Patient reviewers: Maxine Cowlin, Teresa Wilcox
Reviewed: March 2017 (updated Sep 2018)
Next review: March 2019
Primary Sclerosing Cholangitis Basics Leaflet Ref: JD 1.4
- Chapman RW. Primary sclerosing cholangitis. Medicine International. 2015;43(11):648–652.
- Williamson K, Chapman R. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin. 2015;114(1):53-64.
- Lazaridis, KN, LaRusso, NF. Primary Sclerosing Cholangitis. N Engl J Med 2016; 375:1161-1170
- EASL clinical practice guidelines: Management of cholestatic liver diseases. Journal of Hepatology. 2009 Aug;51(2):237–67.
- Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. The Lancet. 2013;382(9904):1587-1599.
- Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG. Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis. Hepatology. 2011 Apr 22;53(5):1590–9.
- Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK. Immune-mediated diseases in primary sclerosing cholangitis. Digestive and Liver Disease. 2011 Oct;43(10):802–6.
- Lindkvist B, Benito de Valle M, Gullberg B, Björnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden. Hepatology. 2010 Mar 23;52(2):571–7.
- Liaskou E, Hirschfield GM. Genetic distinctions in patients with primary Sclerosing Cholangitis: Immunoglobulin G4 elevations and HLA risk. Gastroenterology. 2015 May;148(5):886–9.
Specialist reviewers: Dr Roger W. Chapman, Dr Kate Lynch (née Williamson)
Patient reviewers: Maxine Cowlin, Teresa Wilcox
Reviewed: March 2017
Next review: March 2019
PSC Support Fundraising Leaflet Ref: FR 1.0
- Chapman RW. Primary sclerosing cholangitis. Medicine International. 2015;43(11):648–652.
- Williamson K, Chapman R. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin. 2015;114(1):53-64.
- Lazaridis, KN, LaRusso, NF. Primary Sclerosing Cholangitis. N Engl J Med 2016; 375:1161-1170
- EASL clinical practice guidelines: Management of cholestatic liver diseases. Journal of Hepatology. 2009 Aug;51(2):237–67.
- Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. The Lancet. 2013;382(9904):1587-1599.
- Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG. Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis. Hepatology. 2011 Apr 22;53(5):1590–9.
- Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK. Immune-mediated diseases in primary sclerosing cholangitis. Digestive and Liver Disease. 2011 Oct;43(10):802–6.
- Lindkvist B, Benito de Valle M, Gullberg B, Björnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden. Hepatology. 2010 Mar 23;52(2):571–7.
- Liaskou E, Hirschfield GM. Genetic distinctions in patients with primary Sclerosing Cholangitis: Immunoglobulin G4 elevations and HLA risk. Gastroenterology. 2015 May;148(5):886–9.
Specialist reviewers: Dr Roger W. Chapman, Dr Kate Lynch (née Williamson)
Patient reviewers: Maxine Cowlin, Teresa Wilcox
Reviewed: March 2017
Next review: March 2019